Effects of miR-155 Antisense Oligonucleotide on Breast Carcinoma Cell Line MDA-MB-157 and Implanted Tumors

  • Zheng, Shu-Rong (Department of Oncology, The First Affiliated Hospital of Wenzhou Medical College) ;
  • Guo, Gui-Long (Department of Oncology, The First Affiliated Hospital of Wenzhou Medical College) ;
  • Zhai, Qi (Department of Oncology, The First Affiliated Hospital of Wenzhou Medical College) ;
  • Zou, Zhang-Yong (Department of Oncology, The First Affiliated Hospital of Wenzhou Medical College) ;
  • Zhang, Wei (Department of Oncology, The First Affiliated Hospital of Wenzhou Medical College)
  • Published : 2013.04.30


Diverse studies have shown that miR-155 is overexpressed in different tumor types. However, the precise molecular mechanism of the ectopic expression of miR-155 in breast cancer is still poorly understood. To further explore the role of miR-155 in breast tumorigenesis, we here assessed the influence of miR-155 antisense oligonucleotide (miR-155 ASO) on MDA-MB-157 cell viability and apoptosis in vitro. Furthermore, the effects of inhibitory effects of miR-155 on the growth of xenograft tumors in vivo were determined with performance of immunohistochemistry to detect expression of caspase-3, a pivotal apoptosis regulatory factor, in xenografts. Transfection efficiency detected by laser confocal microscope was higher than 80%. The level of miR-155 expression was significantly decreased (P<0.05) in the cells transfected with miR-155 ASO, compared with that in cells transfected with a negative control. After being transfected with miR-155 ASO, the viability of MDA-MB-157 cells was reduced greatly (P<0.05) and the number of apoptotic cells was increased significantly. Additionally, miR-155 ASO inhibited the growth of transplanted tumor in vivo and significantly increased the expression of caspase-3. Taken together, our study revealed that miR-155 ASO can induce cell apoptosis and inhibit cell proliferation in vitro. Moreover, miR-155 ASO could significantly repress tumor growth in vivo, presumably by inducing apoptosis via caspase-3 up-regulation. These findings provide experimental evidence for using miR-155 as a therapeutic target of breast carcinoma.


  1. Zheng SR, Guo GL, Zhang W, et al (2012). Clinical significance of miR-155 expression in breast cancer and effects of miR-155 ASO on cell viability and apoptosis. Oncol Rep, 27, 1149-55.
  2. Bhattacharyya S, Balakathiresan NS, Dalgard C, et al (2011). Elevated miR-155 promotes inflammation in cystic fibrosis by driving hyperexpression of interleukin-8. J Biol Chem, 286, 11604-15.
  3. Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM (2003). Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell, 113, 25-36.
  4. Busch M, Zernecke A (2012). microRNAs in the regulation of dendritic cell functions in inflammation and atherosclerosis. J Mol Med (Berl), 90, 877-85.
  5. Chen CZ, Li L, Lodish HF, Bartel DP (2004). MicroRNAs modulate hematopoietic lineage differentiation. Science, 303, 83-6.
  6. Ambros V (2003). MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell, 113, 673-6.
  7. Bartel DP (2009). MicroRNAs: target recognition and regulatory functions. Cell, 136, 215-33.
  8. Dong F, Lou D (2012). MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets. Mol Vis, 18, 537-46.
  9. Donnem T, Fenton CG, Lonvik K, et al (2012). MicroRNA signatures in tumor tissue related to angiogenesis in nonsmall cell lung cancer. PLoS One, 7, e29671.
  10. Ghorpade DS, Leyland R, Kurowska-Stolarska M, Patil SA, Balaji KN (2012). MicroRNA-155 Is Required for Mycobacterium bovis BCG-Mediated Apoptosis of Macrophages. Mol Cell Biol, 32, 2239-53.
  11. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ (2006). miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res, 34 (Database issue), D140-4.
  12. Hammond SM (2007). MicroRNAs as tumor suppressors. Nat Genet, 39, 582-3.
  13. Hayashita Y, Osada H, Tatematsu Y, et al (2005). A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res, 65, 9628-32.
  14. He L, Thomson JM, Hemann MT, et al (2005). A microRNA polycistron as a potential human oncogene. Nature, 435, 828-33.
  15. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
  16. Jiang S, Zhang HW, Lu MH, et al (2010). MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res, 70, 3119-27.
  17. Kong W, He L, Coppola M, et al (2010). MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. J Biol Chem, 285, 17869-79.
  18. Lee RC, Feinbaum RL, Ambros V (1993). elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75, 843-54.
  19. Li J, Huang H, Sun L, et al (2009). MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor. Clin Cancer Res, 15, 3998-4008.
  20. Li Y, Zhu X, Gu J, et al (2010). Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis. Hematology, 15, 215-21.
  21. Louafi F, Martinez-Nunez RT, Sanchez-Elsner T (2010). MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-{beta}. J Biol Chem, 285, 41328-36.
  22. O'Connell RM, Kahn D, Gibson WS, et al (2010). MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity, 33, 607-19.
  23. Oertli M, Engler DB, Kohler E, et al (2011). MicroRNA-155 is essential for the T cell-mediated control of Helicobacter pylori infection and for the induction of chronic Gastritis and Colitis. J Immuno, 187, 3578-86.
  24. Ovcharenko D, Kelnar K, Johnson C, Leng N, Brown D (2007). Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway. Cancer Res, 67, 10782-8.
  25. Papagiannakopoulos T, Shapiro A, Kosik KS (2008). MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res, 68, 8164-72.
  26. Porter AG, J nicke RU (1999). Emerging roles of caspase-3 in apoptosis. Cell Death Differ, 6, 99-100.
  27. Tam W, Dahlberg JE (2006). miR-155/BIC as an oncogenic microRNA. Genes Chromosomes Cancer, 45, 211-2.
  28. Urbich C, Kuehbacher A, Dimmeler S (2008). Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res, 79, 581-8.
  29. Vasilatou D, Papageorgiou S, Pappa V, Papageorgiou E, Dervenoulas J (2010). The role of microRNAs in normal and malignant hematopoiesis. Eur J Haematol, 84, 1-16.
  30. Wang HQ, Yu XD, Liu ZH, et al (2011). Deregulated miR-155 promotes Fas-mediated apoptosis in human intervertebral disc degeneration by targeting FADD and caspase-3. J Pathol, 225, 232-42.
  31. Yao R, Ma Y, Du Y, et al (2011). The altered expression of inflammation-related microRNAs with microRNA-155 expression correlates with Th17 differentiation in patients with acute coronary syndrome. Cell Mol Immunol, 8, 486-95.
  32. Yin Q, Wang X, Fewell C, et al (2010). MicroRNA miR-155 inhibits bone morphogenetic protein (BMP) signaling and BMP-mediated Epstein-Barr virus reactivation. J Virol, 84, 6318-27.
  33. Yip L, Kelly L, Shuai Y, et al (2011). MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma. Ann Surg Oncol, 18, 2035-41.
  34. Yu Z, Jian Z, Shen SH, Purisima E, Wang E (2007). Global analysis of microRNA target gene expression reveals that miRNA targets are lower expressed in mature mouse and Drosophila tissues than in the embryos. Nucleic Acids Res, 35, 152-64.
  35. Zhang RG, Zhang RP, Wang XW, Xie H (2002). Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells. Cell Res, 12, 55-62.

Cited by

  1. Unshackling caspase-7 for cancer therapy vol.123, pp.9, 2013,
  2. Evolution of the Mir-155 Family and Possible Targets in Cancers and the Immune System vol.15, pp.18, 2014,
  3. miR-421, miR-155 and miR-650: Emerging Trends of Regulation of Cancer and Apoptosis vol.15, pp.5, 2014,
  4. Downregulation of microRNA-155 accelerates cell growth and invasion by targeting c-myc in human gastric carcinoma cells vol.32, pp.3, 2014,
  5. Antisense oligonucleotides: modifications and clinical trials vol.5, pp.10, 2014,
  6. Antisense oligonucleotides against microRNA-21 reduced the proliferation and migration of human colon carcinoma cells vol.15, pp.1, 2015,
  7. Role of miR-155 in drug resistance of breast cancer vol.36, pp.3, 2015,
  8. Does miRNA-155 Promote Cyclooxygenase-2 Expression in Cancer? vol.76, pp.7, 2015,
  9. microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer vol.91, pp.2, 2015,
  10. Targeting MicroRNAs in Cancer Gene Therapy vol.8, pp.1, 2017,
  11. TNF-α alters the release and transfer of microparticle-encapsulated miRNAs from endothelial cells vol.46, pp.22, 2014,
  12. Effect of microRNA-128 on cisplatin resistance of glioma SHG-44 cells by targeting JAG1 vol.119, pp.4, 2017,